BeStock  

Xeris Pharmaceuticals XERS

US equityMarket cap rank #2408Drug Manufacturers - Specialty & Generic
$16.97 +$0.35 (+2.11%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $17.00 +0.18%
Open$16.61
Prev close$16.62
Day range$16.53 – $17.04
Volume2.86M
Market cap$3.10B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$107.23M+44.2% YoY
Operating profit$16.92M+151.4% YoY
Net profit$11.29M+1,718.0% YoY
Diluted EPS$0.06
Free cash flow$35.31M+92.3% YoY
Operating cash flow$35.47M

Revenue, last 8 quarters

$60.1MDec '24$60.1MMar '25$71.5MJun '25$74.4MSep '25$85.8MDec '25$83.1MMar '26$92.1MJun '26$107.2MSep '26

Net profit, last 8 quarters

$-5.1MDec '24$-9.2MMar '25$-1.9MJun '25$621.0KSep '25$11.1MDec '25$2.2MMar '26$-31.1MJun '26$11.3MSep '26

Diluted EPS by quarter

-0.03Dec '24-0.06Mar '25-0.01Jun '250.00Sep '250.06Dec '250.01Mar '26-0.18Jun '260.06Sep '26

Free cash flow by quarter

$1.8MDec '24$-10.0MMar '25$-97.0KJun '25$18.4MSep '25$19.7MDec '25$9.5MMar '26$8.1MJun '26$35.3MSep '26

Annual revenue

$20.4MFY20$49.6MFY21$110.2MFY22$163.9MFY23$203.1MFY24$291.8MFY25

Profitability & balance sheet

Gross margin87.4%
Operating margin12.7%
Net margin-1.8%
Return on equity-27.1%
Return on assets-1.6%
Return on invested capital6.0%
Current ratio2.15
Liabilities / assets88.5%
Cash & investments$131.08M
Total debt$219.72M
Net cash (debt)-$88.64M
Free cash flow / sales19.7%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Recorlev$71.54M 66.7%
  • Gvoke$21.71M 20.2%
  • Keveyis$13.02M 12.1%
  • Royalty, contract and other revenue$958,000.00 0.9%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $107.23M $92.10M $83.13M $291.85M $85.81M
Total Operating Revenue $107.23M $92.10M $83.13M $291.85M $85.81M
Cost of Revenue $12.43M $12.51M $10.57M $42.57M $10.95M
Gross Profit $94.80M $79.59M $72.55M $249.28M $74.86M
Operating Expense $77.88M $74.42M $64.64M $224.38M $58.09M
Selling and Admin Expenses $64.11M $61.04M $53.14M $182.37M $47.50M
Research & Development $11.06M $10.67M $8.78M $31.17M $7.87M
Depreciation & Amortization & Depletion $2.71M $2.71M $2.71M $10.84M $2.71M
-Depreciation & Amortization $2.71M $2.71M $2.71M $10.84M $2.71M
Operating Profit $16.92M $5.17M $7.92M $24.90M $16.77M
Net Non-Operating Interest Income (Expense) -$5.63M -$5.49M -$5.68M -$24.34M -$5.69M
Non-Operating Interest Income $827,000.00 $1.46M $1.20M $4.74M $1.46M
Non-Operating Interest Expense $6.46M $6.95M $6.88M $29.08M $7.15M
Special Income (Charges) $0.00 -$30.78M – $0.00 $0.00
Pretax Profit $11.29M -$31.10M $2.23M $554,000.00 $11.08M
Tax $0.00 $0.00 $0.00 $0.00 $0.00
Net Profit $11.29M -$31.10M $2.23M $554,000.00 $11.08M
Profit from Continuing Operations $11.29M -$31.10M $2.23M $554,000.00 $11.08M
Net Income to Parent Company $11.29M -$31.10M $2.23M $554,000.00 $11.08M
Net Income to Common Stockholders $11.29M -$31.10M $2.23M $554,000.00 $11.08M
Basic EPS $0.06 -$0.18 $0.01 $0.00 $0.07
Diluted EPS $0.06 -$0.18 $0.01 $0.00 $0.06
Other Income (Expense) – -$30.78M – – –
-Less:Other Special Charges – $30.78M – – –
-Less:Restructuring and Mergern & Acquisition – – – $0.00 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $423.22M $411.91M $392.01M $383.53M $383.53M
Total Current Assets $289.27M $274.76M $251.68M $240.31M $240.31M
Cash and Cash Equivalents & Short-Term Investments $131.08M $121.75M $111.75M $111.04M $111.04M
-Cash and Cash Equivalents $131.08M $121.75M $111.75M $111.04M $111.04M
Receivables $68.60M $58.11M $56.30M $51.05M $51.05M
-Accounts Receivable $68.60M $58.11M $56.30M $51.05M $51.05M
Inventory $76.93M $80.93M $74.23M $68.67M $68.67M
Other Current Assets $12.66M $13.98M $9.40M $9.55M $9.55M
Total Non-Current Assets $133.95M $137.15M $140.33M $143.21M $143.21M
Net PPE $26.22M $26.61M $26.98M $27.06M $27.06M
-Gross PPE $35.22M $35.44M $35.50M $35.23M $35.23M
-Accumulated Depreciation -$9.00M -$8.84M -$8.51M -$8.18M -$8.18M
Goodwill and Other Intangible Assets $102.81M $105.52M $108.23M $110.94M $110.94M
-Goodwill $22.86M $22.86M $22.86M $22.86M $22.86M
-Other Intangible Assets $79.95M $82.66M $85.37M $88.08M $88.08M
Other Non-Current Assets $4.93M $5.03M $5.12M $5.22M $5.22M
Total Liabilities $374.44M $421.64M $379.00M $369.84M $369.84M
Total Current Liabilities $134.48M $189.57M $118.59M $109.57M $109.57M
Payables $8.04M $9.34M $11.47M $3.08M $3.08M
-Accounts Payable $8.04M $9.34M $11.47M $3.08M $3.08M
Current Accrued Expenses $64.90M $59.23M $59.05M $52.35M $52.35M
Short-Term Debt and Capital Lease Obligation $6.35M $70.09M $6.27M $6.23M $6.23M
-Current Capital Lease Obligation $6.35M $6.31M $6.27M $6.23M $6.23M
Current Provisions $17.67M $18.60M $18.72M $18.97M $18.97M
Other Current Liabilities $4.02M $4.98M $4.35M $4.89M $4.89M
Total Non-Current Liabilities $239.96M $232.07M $260.41M $260.26M $260.26M
Long Term Debt and Capital Lease Obligation $219.72M $219.35M $252.28M $251.87M $251.87M
-Long Term Debt $189.71M $188.81M $221.22M $220.34M $220.34M
-Long Term Capital Lease Obligation $30.00M $30.54M $31.06M $31.53M $31.53M
Other Non-Current Liabilities $20.24M $12.72M $8.13M $8.40M $8.40M
Total Equity $48.78M -$9.73M $13.01M $13.69M $13.69M
Stockholders' Equity $48.78M -$9.73M $13.01M $13.69M $13.69M
Capital Stock $19,000.00 $18,000.00 $18,000.00 $17,000.00 $17,000.00
-Common Stock $19,000.00 $18,000.00 $18,000.00 $17,000.00 $17,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $737.66M $690.43M $682.09M $685.00M $685.00M
Retained Earnings -$688.88M -$700.17M -$669.07M -$671.31M -$671.31M
Gains/Losses Not Affecting Retained Earnings -$11,000.00 -$10,000.00 -$24,000.00 -$25,000.00 -$25,000.00
-Current Debt – $63.78M – – –

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $35.47M $8.26M $9.87M $28.63M $20.04M
Net cash flow from continuing operations $35.47M $8.26M $9.87M $28.63M $20.04M
Net Income from Continuing Operations $11.29M -$31.10M $2.23M $554,000.00 $11.08M
Gain/Loss from Continuing Operations $0.00 – – – –
Depreciation & Depletion & Amortization $3.22M $3.21M $3.21M $12.69M $3.20M
Other Non-Cash Items $906,000.00 $907,000.00 $889,000.00 $3.37M $866,000.00
Change in Working Capital $9.25M -$6.60M -$603,000.00 -$10.36M -$373,000.00
-Change in Receivables -$10.49M -$1.81M -$5.25M -$10.64M $2.70M
-Change in Inventory $2.70M -$9.50M $851,000.00 -$19.29M -$4.01M
-Change in Prepaid Assets $1.33M -$4.49M $145,000.00 -$2.10M $1.25M
-Change in Payables and Accrued Expense $15.61M $4.82M $9.01M $19.62M -$1.98M
-Change in Other Current Liabilities -$499,000.00 -$477,000.00 -$434,000.00 -$1.58M -$422,000.00
-Change In Other Working Capital $602,000.00 $4.85M -$4.93M $3.61M $2.09M
Net cash flow from investing -$159,000.00 -$209,000.00 -$325,000.00 -$696,000.00 -$333,000.00
Net Cash Flow from Continuing Investing Activities -$159,000.00 -$209,000.00 -$325,000.00 -$696,000.00 -$333,000.00
Capital Expenditure -$159,000.00 -$209,000.00 -$325,000.00 -$696,000.00 -$333,000.00
Financing Cash Flow -$25.98M $1.94M -$8.84M $11.39M -$266,000.00
Net Cash Flow from Continuing Financing Activities -$25.98M $1.94M -$8.84M $11.39M -$266,000.00
Net Common Stock Issuance -$752,000.00 $409,000.00 -$9.68M -$1.71M -$1.54M
Proceeds from Stock Option Exercised -$2.15M $1.53M $847,000.00 $13.10M $1.27M
Ending Cash Balance $135.10M $125.77M $115.77M $115.06M $115.06M
Net Change in Cash $9.34M $10.00M $708,000.00 $39.32M $19.44M
Beginning Cash Balance $125.77M $115.77M $115.06M $75.74M $95.62M
Free Cash Flow $35.31M $8.05M $9.55M $27.93M $19.71M
Deferred Tax – – – $0.00 $0.00
Net Investment Purchase and Sale – – – $0.00 $0.00
Net Issuance Payments Of Debt – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on XERS.

Sign in to join the discussion.

Scroll to Top